These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3530352)

  • 1. Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patients.
    Verhagen C; de Pauw BE; de Witte T; Holdrinet RS; Janssen JT; Williams KJ
    Blut; 1986 Oct; 53(4):333-9. PubMed ID: 3530352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expansion of erythropoiesis and granulopoiesis after bone marrow grafts].
    Rio B; Cadiou M; Andreu G; Ifrah N; Teyssandier I; Coly E; Soria J; Zittoun R
    Nouv Rev Fr Hematol (1978); 1986; 28(6):349-54. PubMed ID: 3550692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation.
    Speck B
    Acta Haematol; 1984; 72(3):145-54. PubMed ID: 6438978
    [No Abstract]   [Full Text] [Related]  

  • 4. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
    Santos GW; Sensenbrenner LL; Anderson PN; Burke PJ; Klein DL; Slavin RE; Schacter B; Borgaonkar DS
    Transplant Proc; 1976 Dec; 8(4):607-10. PubMed ID: 11591
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
    Labar B; Bogdanic V; Kastelan A; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B; Francetic I; Dobric I; Grgicevic D; Kerhin-Brkljacic V
    Biomed Pharmacother; 1986; 40(9):332-7. PubMed ID: 3548836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for aplastic anemia or acute leukemia.
    Thomas ED
    Scand J Urol Nephrol Suppl; 1977; (42):6-11. PubMed ID: 356224
    [No Abstract]   [Full Text] [Related]  

  • 12. Cure of hematologic neoplasia with transplantation of marrow from identical twins.
    Fefer A; Buckner CD; Thomas ED; Cheever MA; Clift RA; Glucksberg H; Neiman PE; Storb R
    N Engl J Med; 1977 Jul; 297(3):146-8. PubMed ID: 325414
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow transplantation for leukemia and aplastic anemia.
    Thomas ED; Buckner CD; Cheever MA; Clift RA; Einstein AB; Fefer A; Neiman PE; Sanders J; Storb R; Weiden PL
    Transplant Proc; 1976 Dec; 8(4):603-5. PubMed ID: 11590
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow transplantation in cancer patients].
    Morishima Y
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2922-9. PubMed ID: 3532958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and results in bone marrow transplantation].
    Jeannet M; Chapuis B
    Ther Umsch; 1986 Feb; 43(2):138-43. PubMed ID: 3515608
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis.
    Elfenbein GJ; Anderson PN; Humphrey RL; Mullins GM; Sensenbrenner LL; Wands JR; Santos GW
    Transplant Proc; 1976 Dec; 8(4):641-6. PubMed ID: 136774
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.
    Powles RL; Clink HM; Spence D; Morgenstern G; Watson JG; Selby PJ; Woods M; Barrett A; Jameson B; Sloane J; Lawler SD; Kay HE; Lawson D; McElwain TJ; Alexander P
    Lancet; 1980 Feb; 1(8164):327-9. PubMed ID: 6101787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.